# Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19

> **NCT04386070** · PHASE3 · SUSPENDED · sponsor: **University of Birmingham** · enrollment: 6400 (estimated)

## Conditions studied

- Pulmonary Complications in Surgical Patients
- COVID
- Severe Acute Respiratory Syndrome

## Interventions

- **DRUG:** RESP301

## Key facts

- **NCT ID:** NCT04386070
- **Lead sponsor:** University of Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2022-05-16
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-03-01
- **Target enrollment:** 6400 (ESTIMATED)
- **Why stopped:** Lack of IMP availability - may resume.
- **Last updated:** 2025-02-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04386070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04386070, "Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04386070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*